MANDY MOORE: Open Payments
NPI 1396168118 · CLERMONT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,013 in 147 payments from 20 companies in 2025. Trend: 2023 $2,498 · 2024 $2,610 · 2025 $3,013
Food & beverage: $2,848Education: $165
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $539 |
| Novartis Pharmaceuticals Corporation | 15 | $335 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $237 |
| Regeneron Healthcare Solutions, Inc. | 9 | $230 |
| LEO Pharma Inc. | 10 | $223 |
| ABBVIE INC. | 12 | $170 |
| Amgen Inc. | 9 | $167 |
| Arcutis Biotherapeutics, Inc. | 17 | $158 |
| PFIZER INC. | 10 | $143 |
| Organon LLC | 7 | $141 |
Products named: TREMFYA, DUPIXENT, ADBRY, OTEZLA, Zoryve, CIBINQO, Sotyktu, SOFDRA.
Industry payments across FL — which companies pay providers there.
